Research & Development

Unlocking the Potential of Value-Added Medicines in Modern Healthcare
Research & Development Unlocking the Potential of Value-Added Medicines in Modern Healthcare

The 21st century has seen the pharmaceutical industry face mounting challenges such as escalating competition and pricing pressures. Consequently, developers and manufacturers are pioneering innovative strategies to differentiate their products and instill value, particularly in the saturated

Proteo-Genomics Study Reveals New Insights Into Gut Microbiome and Health
Research & Development Proteo-Genomics Study Reveals New Insights Into Gut Microbiome and Health

The human gut microbiome plays a crucial role in overall health, influencing everything from digestion to immune function. Recent advancements in proteo-genomics have provided unprecedented insights into the complex interactions within the gut microbiome. A groundbreaking study has utilized

Can Psychedelics Revolutionize Treatment for Resistant Depression?
Research & Development Can Psychedelics Revolutionize Treatment for Resistant Depression?

In a groundbreaking development, the recent trials of a drug developed by Ireland-based psychedelics biotech company GH Research have showcased its potential in treating treatment-resistant depression. The mid-stage clinical trial, comprising 81 participants, revealed a significant reduction in

How Can AI Transform Safety Event Reporting in Pharmaceuticals?
Research & Development How Can AI Transform Safety Event Reporting in Pharmaceuticals?

Pharmaceutical manufacturers are tasked with the critical responsibility of monitoring and reporting safety events to ensure patient safety and regulatory compliance. This process involves detecting, documenting, evaluating, reporting, and following up on adverse events, product quality complaints,

Can An Experimental Drug GL-II-73 Reverse Alzheimer's Memory Loss?
Research & Development Can An Experimental Drug GL-II-73 Reverse Alzheimer's Memory Loss?

Imagine a world where the devastating effects of Alzheimer's disease can be reversed through an innovative new drug. This scenario may soon become a reality, thanks to groundbreaking research from the Centre for Addiction and Mental Health (CAMH). The study investigates the impact of GL-II-73,

Can Exenatide Offer Hope for Parkinson's Disease Treatment?
Research & Development Can Exenatide Offer Hope for Parkinson's Disease Treatment?

The search for effective treatments for Parkinson's disease has been long and arduous, with researchers globally dedicating countless hours to uncover potential therapies. One promising candidate, exenatide, a GLP-1 drug traditionally used to treat Type 2 diabetes, recently underwent scrutiny

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later